Advertisement
Screener

MARINUS PHARMACEUTICALS, INC. Patents: Active

MARINUS PHARMACEUTICALS, INC. Active Patents

7 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-10-03: Application 18905502; Invention GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX AND SEIZURE DISORDERS; Applicant Marinus Pharmaceuticals, Inc.; Status Patented Case.
  • 2024-02-05: Application 18432492; Invention GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX AND SEIZURE DISORDERS; Applicant Marinus Pharmaceuticals. Inc.; Status Patented Case.
  • 2023-04-26: Application 18307048; Invention GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX; Applicant Marinus Pharmaceuticals, Inc.; Status Patented Case.
  • 2022-04-26: Application 17729427; Invention GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS; Applicant MARINUS PHARMACEUTICALS, INC.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2024-10-0318905502GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX AND SEIZURE DISORDERSMarinus Pharmaceuticals, Inc.Patented Case2025-04-0812268696US20250025475A1
Joseph HULIHAN
Alex AIMETTI
Scott BRAUNSTEIN
United States
United States
United States
HOWELL, THEODORE R
2024-02-0518432492GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX AND SEIZURE DISORDERSMarinus Pharmaceuticals. Inc.Patented Case2024-10-1512115169US20240173336A1
Joseph HULIHAN
Alex AIMETTI
Scott BRAUNSTEIN
United States
United States
United States
HOWELL, THEODORE R
2023-04-2618307048GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEXMarinus Pharmaceuticals, Inc.Patented Case2024-05-1411980625US20240100067A1
Alex AIMETTI
Joseph HULIHAN
Scott BRAUNSTEIN
United States
United States
United States
HUI, SAN MING R
2022-04-2617729427GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUSMARINUS PHARMACEUTICALS, INC.Patented Case2023-06-2011679117US20220265680A1
David CZEKAI
Maciej GASIOR
Lorianne MASUOKA
Julia TSAI
Joseph HULIHAN
Alex AIMETTI
United States
United States
United States
United States
United States
United States
AZPURU, CARLOS A
2022-03-0117683624GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEXMarinus Pharmaceuticals, Inc.Patented Case2023-07-1811701367US20220211723A1
Alex AIMETTI
Joseph HULIHAN
Scott BRAUNSTEIN
United States
United States
United States
HUI, SAN MING R
2021-08-0417393566GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUSMarinus Pharmaceuticals, Inc.Patented Case2025-03-1112246026US20220202831A1
David CZEKAI
Maciej GASIOR
Lorianne MASUOKA
Julia TSAI
Joseph HULIHAN
Alex AIMETTI
United States
United States
United States
United States
United States
United States
AZPURU, CARLOS A
2021-02-2617186569GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUSMarinus Pharmaceuticals, Inc.Patented Case2021-09-0711110100US20210186987A1
David CZEKAI
Maciej GASIOR
Lorianne MASUOKA
Julia TSAI
Joseph HULIHAN
Alex AIMETTI
United States
United States
United States
United States
United States
United States
AZPURU, CARLOS A